About
PTS Diagnostics is a global company based in Whitestown, Indiana, specializing in point-of-care diagnostic products for cardiovascular and diabetes risk assessment. Founded in 1992, the company operates manufacturing facilities in Indianapolis and Sunnyvale, with sales offices across North America, Europe, Latin America, and the Pacific Rim, distributing products in over 135 countries. The company offers a range of innovative testing systems, including the CardioChek family of lipid analyzers, which provide rapid results for lipid panels and glucose levels, and the A1CNow devices for diabetes management. Their PTS Connect solution enhances population health management for healthcare providers, while the CardioChek Health Risk Assessment software aids in evaluating cardiovascular risk. PTS Diagnostics serves healthcare professionals, clinics, and patients, focusing on delivering fast and accurate diagnostic tools to improve health outcomes. With around 242 employees and annual revenues of approximately $44.9 million, PTS Diagnostics plays a significant role in the early detection and management of chronic diseases globally.
Technologies
Keywords
Company Information
-
Employees 170
-
Founded 1992
-
Annual Revenue $45000000
Location
4600 Anson Blvd, Whitestown, Indiana, United States, 46075
